
The WHO/Europe opened the respiratory season with a direct call to get vaccinated against influenza and COVID-19 this fall–winter, stressing that SARS-CoV-2 circulation increased over the summer and that flu rebounds every autumn in the region; the agency notes that older adults,
Read more: CDC sees moderate season; protect high-risk groups with vaccination

El sarampión volvió a las aulas en Carolina del Sur con un brote concentrado en el Upstate: el Departamento de Salud estatal confirmó 16 casos en 2025 (12 en el condado de Spartanburg) y ordenó cuarentenas de 21 días para estudiantes no vacunados expuestos en Global Academy y Fairforest
Read more: South Carolina reports school measles cases and quarantines

Samsung has taken a bold step toward merging health and technology with the announcement of two groundbreaking innovations: the early detection of Left Ventricular Systolic Dysfunction (LVSD) through its Galaxy Watches, and the development of a new ear-mounted EEG
Read more: “Samsung unveils health innovations for Galaxy Watch and brain monitoring”

Japanese telecommunications giant NTT DOCOMO, in partnership with startup PaMeLa, has unveiled a groundbreaking technology designed to measure and reproduce individual perceptions of pain, marking a major milestone in the intersection of neuroscience and
Read more: “Japan pioneers new technology to measure and share human pain”

The scientific community is increasingly focusing on the Omega-3 Index as a critical biomarker for evaluating cardiovascular health. This index measures the proportion of Omega-3 fatty acids in red blood cells, offering an accurate reflection of long-term levels in the body and their impact on heart protection.

The prospect of a U.S. government shutdown is raising major concerns in the healthcare sector, as it could furlough 41% of the workforce at the nation’s leading health agencies. Critical institutions such as the Food and Drug Administration (FDA), the Centers for Disease Control

Health authorities in the state of Massachusetts confirmed two new cases of West Nile Virus over the weekend, raising the risk level to “high” in several local communities. According to the Department of Public Health, the cases involve a woman in her 60s from Middlesex County and a man in
Read more: Massachusetts Raises Risk Level After New West Nile Virus Cases Confirmed

U.S. President Donald Trump sparked major controversy after declaring over the weekend that “we have an answer to autism and we will not allow it to happen again,” comments that he later expanded on during a press conference described as a “major announcement.” According to the president, experts from
Read more: Trump Sparks Controversy Linking Paracetamol Use in Pregnancy to Autism

U.S. health authorities in Louisiana have confirmed that at least five people have died this year as a result of infections caused by the bacterium Vibrio vulnificus, commonly known as the “flesh-eating bacteria.” In total, 26 cases of infection have been reported in the region, most linked to open wounds
Read more: “Louisiana Reports Five Deaths Linked to Deadly Flesh-Eating Bacteria”

A new study published in the prestigious journal JAMA has revealed a significant deterioration in children’s health across the United States between 2007 and 2023, raising serious concerns in the medical and educational communities. The research, conducted by specialists from the Children’s Hospital of
Read more: “Study warns of worsening children’s health across the United States”

The Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that COVID-19 vaccination should no longer be a universal requirement for everyone over the age of six months, but rather an individualized decision. According to the
Read more: “CDC shifts vaccination strategy, leaving COVID-19 shots to patients”

The U.S. Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Keytruda, Merck’s flagship immunotherapy for cancer. This version, called Keytruda Qlex, represents a significant advancement in how the treatment is administered, as it allows patients to receive their dose
Read more: "FDA Approves Subcutaneous Version of Keytruda for Cancer Patients"